The use of esketamine in the treatment of patients with oral antidepressant-resistant depression: systematic review and meta-analysis.
Journal
Revista da Associacao Medica Brasileira (1992)
ISSN: 1806-9282
Titre abrégé: Rev Assoc Med Bras (1992)
Pays: Brazil
ID NLM: 9308586
Informations de publication
Date de publication:
2023
2023
Historique:
received:
06
04
2023
accepted:
19
04
2023
medline:
29
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field to standardize how to conduct, and to assist in the reasoning and decision-making of doctors. The information provided by this project must be critically evaluated by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical condition of each patient. Guideline conclusion: April 2023. Societies: Brazilian Medical Association.
Identifiants
pubmed: 37377288
pii: S0104-42302023000600200
doi: 10.1590/1806-9282.2023D696
pmc: PMC10305833
pii:
doi:
Substances chimiques
Esketamine
50LFG02TXD
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2023D696Références
Biol Psychiatry. 2003 Apr 15;53(8):707-42
pubmed: 12706957
JAMA Psychiatry. 2019 Sep 1;76(9):893-903
pubmed: 31166571
J Clin Psychiatry. 2020 May 26;81(4):
pubmed: 32459407
J Clin Psychiatry. 2020 Apr 21;81(3):
pubmed: 32316080
BMC Psychiatry. 2021 Oct 25;21(1):526
pubmed: 34696742
Arch Womens Ment Health. 2022 Apr;25(2):313-326
pubmed: 34973081
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Am J Geriatr Psychiatry. 2020 Feb;28(2):121-141
pubmed: 31734084
J Psychopharmacol. 2021 Aug;35(8):890-900
pubmed: 34238049
Biol Psychiatry. 2003 Apr 15;53(8):649-59
pubmed: 12706951
Clin Pharmacol Ther. 2021 Feb;109(2):536-546
pubmed: 32860422
J Clin Psychiatry. 2021 Jul 20;82(4):
pubmed: 34288609
Biol Psychiatry. 2016 Sep 15;80(6):424-431
pubmed: 26707087
J Affect Disord. 2020 Mar 1;264:527-534
pubmed: 31786030
J Manag Care Spec Pharm. 2020 Jan;26(1):16-20
pubmed: 31880219
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Neuropsychiatr Dis Treat. 2021 Jul 15;17:2347-2357
pubmed: 34290505
Int J Neuropsychopharmacol. 2019 Oct 1;22(10):616-630
pubmed: 31290965
J Affect Disord. 2021 Jan 1;278:542-555
pubmed: 33022440
JAMA Psychiatry. 2018 Feb 1;75(2):139-148
pubmed: 29282469
J Psychiatr Res. 2019 Apr;111:68-73
pubmed: 30685564
Trends Pharmacol Sci. 2009 Nov;30(11):563-9
pubmed: 19837463
Int J Neuropsychopharmacol. 2020 Jul 29;23(7):426-433
pubmed: 32270176
J Affect Disord. 2021 Oct 1;293:285-294
pubmed: 34225208
BMC Psychiatry. 2019 Nov 29;19(1):375
pubmed: 31783823
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Am J Psychiatry. 2019 Jun 1;176(6):428-438
pubmed: 31109201
Mol Psychiatry. 2022 Jan;27(1):559-573
pubmed: 33963284